AngioDynamics, Inc. (ANGO) Cash Flow Statement
AngioDynamics, Inc. (ANGO) generated $3.7M of operating cash flow over the twelve months to 2026-08-31, spent $2.2M on capital expenditure and had free cash flow of $1.4M, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-08-31 · read by EquiReason
ANGOAngioDynamics, Inc.Follow ANGO — free
—
Price chart with a free account
- Market cap
- 520.0M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 4 Jan, in 72 days
| Line | FY2011 May 11 | FY2012 May 12 | FY2013 May 13 | FY2014 May 14 | FY2015 May 15 | FY2016 May 16 | FY2017 May 17 | FY2018 May 18 | FY2019 May 19 | FY2020 May 20 | FY2021 May 21 | FY2022 May 22 | FY2023 May 23 | FY2024 May 24 | FY2025 May 25 | FY2026 May 26 | TTM Aug 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | — | 11.6 | 26.7 | 24.7 | 25.7 | 45.2 | 55.7 | 41.3 | 37.4 | -14.6 | 24.1 | -7.2 | 0.1 | -28.2 | -10.1 | 3.1 | 3.7 | |
| Capital expenditure | — | 2.5 | 12.1 | 11.2 | 11.4 | 2.3 | 3.0 | 2.4 | 3.1 | 7.2 | 5.2 | 4.3 | 3.8 | 2.5 | 4.5 | 2.6 | -2.2 | |
| Free cash flow | — | 9.1 | 14.5 | 13.5 | 14.3 | 42.9 | 52.7 | 38.9 | 34.3 | -21.8 | 18.9 | -11.5 | -3.7 | -30.7 | -14.6 | 0.5 | 1.4 | |
| Dividends paid | — | — | 0.0 | 0.0 | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| Share repurchases | — | 2.1 | 0.0 | 0.0 | 0.0 | 0.0 | 13.6 | 0.0 | 0.0 | — | — | — | 0.0 | 0.0 | 1.7 | 0.0 | — | |
| Stock-based compensation | — | 4.1 | 4.6 | 5.5 | 6.0 | 3.2 | 6.2 | 7.9 | 9.2 | 7.6 | 8.6 | 10.7 | 11.2 | 10.5 | 9.8 | 14.0 | — |
USD millions · SEC XBRL
AngioDynamics, Inc. — questions
- What is AngioDynamics, Inc.'s operating cash flow?
- $3.7M over the twelve months to 2026-08-31.
- How much does AngioDynamics, Inc. spend on capital expenditure?
- $2.2M over the twelve months to 2026-08-31.
- What is AngioDynamics, Inc.'s free cash flow?
- $1.4M over the twelve months to 2026-08-31: operating cash flow minus capital expenditure.
Every figure on this page comes from AngioDynamics, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.